OrphanDrug
OrphanDrug
Pharma Knowledge Base

microsporidiosis

MeSH: D016881ORPHA: 2552

Contents

  1. 1. Overview
  2. 2. Available Treatments
  3. 3. Clinical Presentation
  4. 4. Classification & Codes

Overview

opportunistic mycosis that results in systemic fungal infection in immunocompromised people, has material basis in Microsporidia phylum members

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Clinical Presentation

Signs and symptoms associated with microsporidiosis, sourced from HPO and Orphanet clinical annotations.

Weight lossAbdominal painChronic diarrheaIntermittent diarrheaImmunodeficiencySinusitisFeverVomitingNauseaAnorexiaAbnormality of the urinary system physiologyRhinitisBronchitisProstatitisNephritisGlossitisKeratitisVisual lossAbnormality of the parathyroid glandAdrenocortical abnormalityBiliary tract abnormalityKeratoconjunctivitisSeizurePancreatitisAbnormality of the spleenDehydrationPneumoniaInfectious encephalitisPeritonitisOsteomyelitisAbnormal tracheal morphologyLymphadenitisCachexiaAbnormal bone marrow cell morphologyAbnormal vocal cord morphologyAbnormal fallopian tube morphologyBronchiolitisHepatitisCorneal ulcerationMyocarditisPharyngitisBrain abscessAbnormal endometrium morphologyCholangitisEndocarditisMyositisThyroiditisSepsisSkin noduleUrethritisDecreased CD4+ T cell proportion

Classification & Codes

MeSH Code

D016881

Orphanet Code

ORPHA:2552
microsporidiosis
MeSHD016881
OrphanetORPHA:2552
Treatments0 drug(s)
Symptoms on record51 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO